Clinical Trial Update: Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of axicabtagene ciloleucel for relapsed/refractory follicular lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Axicabtagene ciloleucel (axicabtagene ciloleucel)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Lymphoma, Follicular Lymphoma | Phase 2 | Status: RECRUITING